Business Description
Actinogen Medical Ltd
SIC : 2833
ISIN : AU000000ACW3
Description
Actinogen Medical Ltd is an Australian clinical-stage biotechnology company focused on developing treatments for neurological and neuropsychiatric conditions linked to elevated cortisol in the brain. Its lead candidate is Xanamem, an oral, brain-penetrant inhibitor of the enzyme 11beta-HSD1, which is designed to lower cortisol levels within brain cells. The company is advancing Xanamem through clinical trials in indications such as Alzheimer's disease, Fragile X syndrome, and other cognitive and neuropsychiatric disorders. Actinogen operates primarily in Australia, where it conducts research and development activities, and it is listed on the Australian Securities Exchange. As a clinical-stage company, it has no marketed products and generates no product revenue, relying instead on equity financing and capital raising to fund its research and development programs.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 3.5 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -0.33 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 7.2 | |||||
3-Year EPS without NRI Growth Rate | 5.9 | |||||
3-Year Book Growth Rate | -5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 71.71 | |||||
9-Day RSI | 74.67 | |||||
14-Day RSI | 76.04 | |||||
6-1 Month Momentum % | -97.43 | |||||
12-1 Month Momentum % | -96.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.45 | |||||
Quick Ratio | 3.45 | |||||
Cash Ratio | 2.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -24.7 | |||||
Shareholder Yield % | -7.64 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -95.97 | |||||
ROA % | -71.38 | |||||
ROIC % | -493.03 | |||||
3-Year ROIIC % | -278.01 | |||||
ROC (Joel Greenblatt) % | -5090.1 | |||||
ROCE % | -92.26 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 35 | |||||
PB Ratio | 10 | |||||
Price-to-Tangible-Book | 3.5 | |||||
EV-to-EBIT | -14.5 | |||||
EV-to-EBITDA | -14.92 | |||||
EV-to-Forward-EBITDA | -5.76 | |||||
EV-to-Forward-Revenue | 5.99 | |||||
EV-to-FCF | -12.31 | |||||
| Price-to-Net-Current-Asset-Value | 3.5 | |||||
Earnings Yield (Greenblatt) % | -6.9 | |||||
FCF Yield % | -7.7 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ATGGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Actinogen Medical Ltd Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.003 | ||
| Beta | 10.7411 | ||
| 3-Year Sharpe Ratio | 0.59 | ||
| 3-Year Sortino Ratio | 21.4 | ||
| Volatility % | 4281.98 | ||
| 14-Day RSI | 76.04 | ||
| 14-Day ATR ($) | 0.001113 | ||
| 20-Day SMA ($) | 0.03449 | ||
| 12-1 Month Momentum % | -96.8 | ||
| 52-Week Range ($) | 0.0008 - 0.04 | ||
| Shares Outstanding (Mil) | 3,847.85 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Actinogen Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Actinogen Medical Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Actinogen Medical Ltd Frequently Asked Questions
What is Actinogen Medical Ltd(ATGGF)'s stock price today?
The current price of ATGGF is $0.04. The 52 week high of ATGGF is $0.04 and 52 week low is $0.00.
When is next earnings date of Actinogen Medical Ltd(ATGGF)?
The next earnings date of Actinogen Medical Ltd(ATGGF) is .
Does Actinogen Medical Ltd(ATGGF) pay dividends? If so, how much?
Actinogen Medical Ltd(ATGGF) does not pay dividend.
Press Release
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers